stars 1 stars 2 stars 3

At Axinesis, we specialise in the industrialisation of medical devices. We operate at the critical stage where a functional prototype must become a robust, manufacturable and regulatory-compliant product. Our role is to secure the transition from design to production through structured industrial processes and strong quality and regulatory governance. We support medtech companies across the full lifecycle, from design transfer through industrialisation, production and post-market support. Our expertise covers: - design transfer and manufacturability optimisation - development and validation of robust industrial processes - implementation of ISO 13485-compliant quality systems - integration and maintenance of MDR-compliant technical documentation This approach enables our clients to reduce industrial risks, ensure product reproducibility and avoid late-stage regulatory bottlenecks. We adapt our level of involvement and operating model to each project, providing tailored support aligned with our clients’ technical, regulatory and industrial needs. We can operate as a CDMO or act as Legal Manufacturer, taking full responsibility for quality and regulatory compliance when required.

AXINESIS Questions

Julien Sapin is the CEO of AXINESIS.

4 people are employed at AXINESIS.

Top AXINESIS Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users